Randomized clinical trial comparing hepatitis B vaccine administered by 0, 6 and 14 week versus 6, 10 and 14 week schedule in healthy infants

Journal of Tropical Pediatrics

Volumn 55, Issue 5, 2009, Pages 328-331

  Das, Rashmi Ranjan ^a   Mathew, Joseph L ^a   Ratho, Radha Kanta ^a   Dutta, Sourabh ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Hepatitis B; Infant; Recombinant vaccine; Schedule

Indexed keywords

RECOMBINANT HEPATITIS B VACCINE;

ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYING; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; FEMALE; HEPATITIS B; HUMAN; HUMAN EXPERIMENT; IMMUNIZATION; INFANT; INJECTION SITE REACTION; INJECTION SITE SORENESS; LETHARGY; LOOSE FECES; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; SIDE EFFECT; SINGLE BLIND PROCEDURE; VACCINATION;

FEMALE; GUIDELINES AS TOPIC; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION SCHEDULE; INDIA; INFANT; STATISTICS, NONPARAMETRIC; TIME FACTORS; TREATMENT OUTCOME; VACCINES, SYNTHETIC;

EID: 73249137807     PISSN: 01426338     EISSN: 14653664     Source Type: Journal    
DOI: 10.1093/tropej/fmp013     Document Type: Article

References (13)

1. No authors cited. Hepatitis B vaccines. WHO position on the use of hepatitis B vaccines. Wkly Epidemiol Rec 2004;79:253-64.
2. IAP Committee on Immunization 2003-2004. IAP Guide Book on Immunization. Mumbai: IAP Publications.
3. Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part 1: Immunization of Infants, Children, and Adolescents. A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States. MMWR 2005;54:1-39.
4. Chakravarti A, Rawat D, Jain M. A study on the perinatal transmission of the hepatitis B virus. Indian J Med Microbiol 2005;23:128-30.
5. Nayak NC, Panda SK, Zuckerman AJ, et al. Dynamics and impact of perinatal transmission of hepatitis B virus in north India. J Med Virol 1987;21:137-45.
6. Sharma R, Malik A, Rattan A, et al. Hepatitis B virus infection in pregnant women and its transmission to infants. J Trop Pediatr 1996;42:352-4.
7. Nijhawan S, Rai RR, Pokharna R, et al. Spectrum of hepatitis B infection in family contacts. Abstract. Ind J Gastroenterol 1999;18(Suppl 1): S21.
8. Mittal SK, Rao S, Rastogi A, et al. Hepatitis B-potential of perinatal transmission in India. Trop Gastroenterol 1996;17:190-2.
9. Kant L, Hall AJ. Epidemiology of childhood hepatitis B in India: vaccination related issues. Indian J Pediatr 1995;62:635-53.
10. Mathew JL, El Dib R, Mathew PJ, et al. Hepatitis B immunization in persons not previously exposed to hepatitis B or with unknown exposure status. Cochrane Database Syst Rev 2007.
11. Gomber S, Sharma R, Ramchandran VG, et al. Immunogenecity of hepatitis B vaccine incorporated into the Expanded Program of Immunization schedule. Indian Pediatr 2000;37:411-3.
12. Giammanco G, Li Volti S, Mauro L, et al. Immune response to simultaneous administration of a recombinant DNA hepatitis B vaccine and multiple compulsory vaccines in infancy. Vaccine 1991;9:747-50.
13. Jain AK, Mittal SK, Ramji S, et al. Hepatitis B vaccine in the EPI schedule. Indian J Pediatr 2005;72:661-4.